A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Clinical trial NCT03714815 · TERMINATED
Trial details
- NCT number
- NCT03714815
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-07
- Primary completion
- 2021-10-12
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.